首页> 外文OA文献 >Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement

【2h】

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement

机译：通过AML1 / ETO重排的儿童急性髓细胞白血病实时定量逆转录PCR（RT-RT-PCR）监测最小残留疾病（MRD）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
S Viehmann; A Teigler-Schlegel; J Bruch; C Langebrake; D Reinhardt; J Harbott;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1|[sol]|ETO rearrangement [J] . S Viehmann, A Teigler-Schlegel, J Bruch, Leukemia . 2003,第6期

机译：实时定量逆转录PCR（RQ-RT-PCR）通过AML1 | [sol] | ETO重排对儿童急性髓细胞性白血病的最小残留疾病（MRD）进行监测
2. Development of a Reverse Transcriptase Quantitative Polymerase Chain Reaction (RT-qPCR) Assay for Nucleophosmin (NPM1) Minimal Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia [J] . Mai M., Viswanatha D. S., He R. The Journal of molecular diagnostics: JMD . 2018,第6期

机译：在急性髓性白血病中，逆转录酶定量聚合酶链反应（RT-QPCR）测定的逆转录酶定量聚合酶链反应（RT-QPCR）测定（MRD）监测
3. Comparative Monitoring of Minimal Residual Disease (MRD) By RT-Quantitative (RT-qPCR) and Digital PCR (dPCR) in Ph plus Chronic Myeloid Leukemia (CML) Patients Treated with TKIs for Recognition of Stable Deep Molecular Response (DMR) and Identification of Best Candidates to TKIs Treatment Discontinuation [J] . Bernardi Simona, Malagola Michele, Zanaglio Camilla, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：对RT-定量（RT-QPCR）的最小残留疾病（MRD）的比较监测pH加慢性骨髓白血病（CML）治疗TKIS治疗稳定深度分子反应（DMR）和鉴定 TKIS治疗中止的最佳候选人
4. Detection of Minimal Residual Disease (MRD) in Patients with Leukemia Using Microfluidic-Based Analysis [C] . Rolf Muller, Bryan Green, Matt Hupert, International Molecular Medicine Tri-Conference. . 2016

机译：使用基于微流体分析的白血病患者最小残留疾病（MRD）的检测
5. PCR amplification of IgH rearrangements for the assessment of minimal residual disease in PBSC harvests for autologous transplantation following administration of monocyte-derived growth factor. [D] . Keenan, James R. 2003

机译：IgH重排的PCR扩增用于评估单核细胞衍生生长因子后自体移植PBSC收获物中的最小残留病害。
6. A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib [O] . Hiroaki Kitamura, Yoko Tabe, Tomohiko Ai, -1

机译：伊马替尼停药后用于检测BCR-ABL1的新高灵敏实时定量PCR方法以监测慢性粒细胞白血病的最小残留病
7. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia [O] . Flohr, T, Schrauder, A, Cazzaniga, G, 2008

机译：在国际多中心试验AIEOP-BFM ALL 2000中对儿童急性淋巴细胞白血病的免疫球蛋白和T细胞受体基因重排进行实时定量PCR分析，从而将残留的疾病定向风险降至最低

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement

著录项

相似文献

相关主题

期刊订阅